LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts.

    Geletu, Mulu / Adan, Hanad / Niit, Maximillian / Arulanandam, Rozanne / Carefoot, Esther / Hoskin, Victoria / Sina, Diana / Elliott, Bruce / Gunning, Patrick / Raptis, Leda

    Experimental cell research

    2021  Volume 411, Issue 1, Page(s) 112731

    Abstract: Adhesion of cells to each other and to the extracellular matrix (ECM) are both required for cellular functions. Cell-to-cell adhesion is mediated by cadherins, and their engagement triggers the activation of Stat3, which offers a potent survival signal. ... ...

    Abstract Adhesion of cells to each other and to the extracellular matrix (ECM) are both required for cellular functions. Cell-to-cell adhesion is mediated by cadherins, and their engagement triggers the activation of Stat3, which offers a potent survival signal. Adhesion to the ECM on the other hand, activates FAK which attracts and activates Src, as well as receptor tyrosine kinases (RTKs), the PI3k/Akt and Ras/Erk pathways. However, the effect of cell density upon FAK and Akt activity has not been examined. We now demonstrate that, interestingly, despite being potent Stat3 activators, Src and RTKs are unable to activate Stat3 in sparsely growing (i.e., without cadherin engagement), non-neoplastic cells attached to the ECM. In contrast, cell aggregation (i.e., cadherin engagement in the absence of adhesion to a solid substratum) was found to activate both Stat3 and Akt. Pharmacologic or genetic reduction of FAK activity abolished Akt activity at low densities, indicating that FAK is an important activator of Akt in this setting. Notably, FAK knockout increased cellular sensitivity to the Stat3 inhibitor CPA7, while FAK reintroduction restored resistance to this drug. These findings suggest a complementary role of integrin/FAK/Akt and cadherin/Stat3-mediated pro-survival pathways, which may be of significance during neoplastic transformation and metastasis.
    Language English
    Publishing date 2021-07-14
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 1493-x
    ISSN 1090-2422 ; 0014-4827
    ISSN (online) 1090-2422
    ISSN 0014-4827
    DOI 10.1016/j.yexcr.2021.112731
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Erratum to "Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts" [Exp. Cell Res. 404 (1) (2021) 112601].

    Geletu, Mulu / Adan, Hanad / Niit, Maximillian / Arulanandam, Rozanne / Carefoot, Esther / Hoskin, Victoria / Sina, Diana / Elliott, Bruce / Gunning, Patrick / Raptis, Leda

    Experimental cell research

    2021  Volume 411, Issue 1, Page(s) 112732

    Language English
    Publishing date 2021-07-30
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 1493-x
    ISSN 1090-2422 ; 0014-4827
    ISSN (online) 1090-2422
    ISSN 0014-4827
    DOI 10.1016/j.yexcr.2021.112732
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts.

    Geletu, Mulu / Adan, Hanad / Niit, Maximillian / Arulanandam, Rozanne / Carefoot, Esther / Hoskin, Victoria / Sina, Diana / Elliott, Bruce / Gunning, Patrick / Raptis, Leda

    Experimental cell research

    2021  Volume 404, Issue 1, Page(s) 112601

    Abstract: Adhesion of cells to each other and to the extracellular matrix (ECM) are both required for cellular functions. Cell-to-cell adhesion is mediated by cadherins and their engagement triggers the activation of Stat3, which offers a potent survival signal. ... ...

    Abstract Adhesion of cells to each other and to the extracellular matrix (ECM) are both required for cellular functions. Cell-to-cell adhesion is mediated by cadherins and their engagement triggers the activation of Stat3, which offers a potent survival signal. Adhesion to the ECM on the other hand, activates FAK which attracts and activates Src, as well as receptor tyrosine kinases (RTKs), the PI3k/Akt and Ras/Erk pathways. However, the effect of cell density upon FAK and Akt activity has not been examined. We now demonstrate that, interestingly, despite being potent Stat3 activators, Src and RTKs are unable to activate Stat3 in sparsely growing (i.e., without cadherin engagement), non-neoplastic cells attached to the ECM. In contrast, cell aggregation (i.e., cadherin engagement in the absence of adhesion to a solid substratum) was found to activate both Stat3 and Akt. Pharmacologic or genetic reduction of FAK activity abolished Akt activity at low densities, indicating that FAK is an important activator of Akt in this setting. Notably, FAK knockout increased cellular sensitivity to the Stat3 inhibitor CPA7, while FAK reintroduction restored resistance to this drug. These findings suggest a complementary role of integrin/FAK/Akt and cadherin/Stat3-mediated pro-survival pathways, which may be of significance during neoplastic transformation and metastasis.
    MeSH term(s) Animals ; Cadherins/metabolism ; Cell Adhesion/physiology ; Cell Survival/physiology ; Cell Transformation, Neoplastic/metabolism ; Extracellular Matrix/metabolism ; Fibroblasts/metabolism ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Humans ; Mice ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; STAT3 Transcription Factor/metabolism ; Signal Transduction/physiology
    Chemical Substances Cadherins ; STAT3 Transcription Factor ; STAT3 protein, human ; Focal Adhesion Protein-Tyrosine Kinases (EC 2.7.10.2) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1)
    Language English
    Publishing date 2021-05-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1493-x
    ISSN 1090-2422 ; 0014-4827
    ISSN (online) 1090-2422
    ISSN 0014-4827
    DOI 10.1016/j.yexcr.2021.112601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.

    Gawel, Justyna M / Shouksmith, Andrew E / Raouf, Yasir S / Nawar, Nabanita / Toutah, Krimo / Bukhari, Shazreh / Manaswiyoungkul, Pimyupa / Olaoye, Olasunkanmi O / Israelian, Johan / Radu, Tudor B / Cabral, Aaron D / Sina, Diana / Sedighi, Abootaleb / de Araujo, Elvin D / Gunning, Patrick T

    European journal of medicinal chemistry

    2020  Volume 201, Page(s) 112411

    Abstract: Dysregulated Histone Deacetylase (HDAC) activity across multiple human pathologies have highlighted this family of epigenetic enzymes as critical druggable targets, amenable to small molecule intervention. While efficacious, current approaches using non- ... ...

    Abstract Dysregulated Histone Deacetylase (HDAC) activity across multiple human pathologies have highlighted this family of epigenetic enzymes as critical druggable targets, amenable to small molecule intervention. While efficacious, current approaches using non-selective HDAC inhibitors (HDACi) have been shown to cause a range of undesirable clinical toxicities. To circumvent this, recent efforts have focused on the design of highly selective HDACi as a novel therapeutic strategy. Beyond roles in regulating transcription, the unique HDAC6 (with two catalytic domains) regulates the deacetylation of α-tubulin; promoting growth factor-controlled cell motility, cell division, and metastatic hallmarks. Recent studies have linked aberrant HDAC6 function in various hematological cancers including acute myeloid leukaemia and multiple myeloma. Herein, we report the discovery, in vitro characterization, and biological evaluation of PTG-0861 (JG-265), a novel HDAC6-selective inhibitor with strong isozyme-selectivity (∼36× ) and low nanomolar potency (IC
    MeSH term(s) Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/metabolism ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Agents/therapeutic use ; Apoptosis/drug effects ; Benzamides/chemical synthesis ; Benzamides/metabolism ; Benzamides/pharmacokinetics ; Benzamides/therapeutic use ; Catalytic Domain ; Cell Line, Tumor ; Histone Deacetylase 6/antagonists & inhibitors ; Histone Deacetylase 6/chemistry ; Histone Deacetylase 6/metabolism ; Histone Deacetylase Inhibitors/chemical synthesis ; Histone Deacetylase Inhibitors/metabolism ; Histone Deacetylase Inhibitors/pharmacokinetics ; Histone Deacetylase Inhibitors/therapeutic use ; Humans ; Hydroxamic Acids/chemical synthesis ; Hydroxamic Acids/metabolism ; Hydroxamic Acids/pharmacokinetics ; Hydroxamic Acids/therapeutic use ; Leukemia, Myeloid, Acute/drug therapy ; Male ; Mice ; Molecular Docking Simulation ; Molecular Structure ; Protein Binding ; Structure-Activity Relationship
    Chemical Substances Antineoplastic Agents ; Benzamides ; Histone Deacetylase Inhibitors ; Hydroxamic Acids ; HDAC6 protein, human (EC 3.5.1.98) ; Histone Deacetylase 6 (EC 3.5.1.98)
    Language English
    Publishing date 2020-06-06
    Publishing country France
    Document type Journal Article
    ZDB-ID 188597-2
    ISSN 1768-3254 ; 0009-4374 ; 0223-5234
    ISSN (online) 1768-3254
    ISSN 0009-4374 ; 0223-5234
    DOI 10.1016/j.ejmech.2020.112411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A functional in vitro assay for screening inhibitors of STAT5B phosphorylation.

    de Araujo, Elvin D / Manaswiyoungkul, Pimyupa / Erdogan, Fettah / Qadree, Abdul K / Sina, Diana / Tin, Gary / Toutah, Krimo / Yuen, Karen / Gunning, Patrick T

    Journal of pharmaceutical and biomedical analysis

    2018  Volume 162, Page(s) 60–65

    Abstract: Inhibition of STAT phosphorylation is recognized as a viable therapeutic strategy for disrupting tumorigenesis. Constitutive STAT phosphorylation is found with high frequency in a number of primary tumor types, while non-cancer cells exhibit low basal ... ...

    Abstract Inhibition of STAT phosphorylation is recognized as a viable therapeutic strategy for disrupting tumorigenesis. Constitutive STAT phosphorylation is found with high frequency in a number of primary tumor types, while non-cancer cells exhibit low basal activity, providing an exploitable therapeutic window. STAT activation involves phosphorylation of the SH
    MeSH term(s) Drug Discovery/methods ; High-Throughput Screening Assays ; Humans ; Kinetics ; Ligands ; Phosphorylation ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins c-abl/antagonists & inhibitors ; Proto-Oncogene Proteins c-abl/metabolism ; Reproducibility of Results ; STAT5 Transcription Factor/metabolism
    Chemical Substances Ligands ; Protein Kinase Inhibitors ; STAT5 Transcription Factor ; STAT5B protein, human ; Proto-Oncogene Proteins c-abl (EC 2.7.10.2)
    Language English
    Publishing date 2018-08-18
    Publishing country England
    Document type Journal Article ; Validation Studies
    ZDB-ID 604917-5
    ISSN 1873-264X ; 0731-7085
    ISSN (online) 1873-264X
    ISSN 0731-7085
    DOI 10.1016/j.jpba.2018.08.036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.

    Shouksmith, Andrew E / Gawel, Justyna M / Nawar, Nabanita / Sina, Diana / Raouf, Yasir S / Bukhari, Shazreh / He, Liying / Johns, Alexandra E / Manaswiyoungkul, Pimyupa / Olaoye, Olasunkanmi O / Cabral, Aaron D / Sedighi, Abootaleb / de Araujo, Elvin D / Gunning, Patrick T

    ACS medicinal chemistry letters

    2019  Volume 11, Issue 1, Page(s) 56–64

    Abstract: The HDAC inhibitor 4- ...

    Abstract The HDAC inhibitor 4-
    Language English
    Publishing date 2019-12-13
    Publishing country United States
    Document type Journal Article
    ISSN 1948-5875
    ISSN 1948-5875
    DOI 10.1021/acsmedchemlett.9b00471
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top